PHOE PHOE
Company Profile ↓Company Overview
PHOE (PHOE) is a publicly traded company listed on with a market capitalization of $421.20M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 33.0%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 41.4%.
Net profit has compounded at 71.0% per year over the last five years.
Revenue has grown at a 81.9% CAGR over the past five years.
Operating margin of 17.6% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2025 Revenue of $7.37M (+28.1% YoY); net profit $1.03M.
- Trailing 12 Months Year-on-year growth — revenue +28.1%, earnings -2.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 81.9%, profit CAGR 71.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 81.86% |
| 1 Year: | 28.06% |
Compounded Profit Growth
| 5 Years: | 70.98% |
| 1 Year: | -2.86% |
Stock Price Performance
| 1 Year: | +142.84% |
| 6 Months: | +18.54% |
| 3 Months: | -58.50% |
| 1 Month: | -20.60% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)46.10 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 33.0%.
- Healthy ROCE of 41.4%.
- Compounding revenue at 81.9% over 5 years.
- Profit CAGR of 71.0% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 398.6.
- Trading 85.3% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Revenue | 2.23M | 5.76M | 7.37M |
| Cost of Revenue | 1.66M | 4.27M | 5.19M |
| Gross Profit | 565.26K | 1.48M | 2.18M |
| Operating Expenses | 188.48K | 251.49K | 878.19K |
| Operating Income | 376.78K | 1.23M | 1.30M |
| EBITDA | 436.82K | 1.28M | 1.35M |
| Interest Expense | 1.14K | 820 | 733 |
| Pretax Income | 391.83K | 1.24M | 1.30M |
| Tax Provision | 40.76K | 183.07K | 270.67K |
| Net Income | 351.06K | 1.06M | 1.03M |
| Diluted EPS | 0.02 | 0.05 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Total Assets | 1.60M | 3.70M | 5.37M |
| Current Assets | 1.39M | 3.46M | 5.02M |
| Cash & Equivalents | 377.75K | 890.58K | 2.38M |
| Inventory | - | - | - |
| Receivables | 997.13K | 2.49M | 1.63M |
| Total Liabilities | 946.10K | 2.00M | 2.26M |
| Current Liabilities | 852.86K | 1.97M | 2.24M |
| Long Term Debt | - | - | - |
| Total Debt | 71.24K | 51.17K | 25.05K |
| Total Equity | 651.96K | 1.71M | 3.11M |
| Shares Outstanding | 21.60M | 21.60M | 21.60M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating Cash Flow | -57.11K | 540.33K | 1.18M |
| Investing Cash Flow | -22.61K | 6.41K | -41.09K |
| Financing Cash Flow | -8.64K | -33.91K | 346.43K |
| Capital Expenditure | -22.61K | - | -41.09K |
| Free Cash Flow | -79.72K | 540.33K | 1.14M |
| Net Change in Cash | -88.36K | 512.83K | 1.49M |
Ratios (Annual)
Figures in %.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Gross Margin % | 25.4% | 25.8% | 29.5% |
| Operating Margin % | 16.9% | 21.4% | 17.6% |
| Net Margin % | 15.8% | 18.4% | 13.9% |
| ROE % | 53.8% | 61.8% | 33.0% |
| ROCE % | 50.6% | 71.0% | 41.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PHOE
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
PALO ALTO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management…
Phoenix Asia Holdings Limited Announces Entering into Stock Acquisition Agreement and Convertible Promissory Note
Hong Kong, May 04, 2026 (GLOBE NEWSWIRE) -- Phoenix Asia Holdings Limited (the “Company” or “Phoenix Asia”) (NASDAQ: PHOE), a Hong Kong-based company mainly engaged in substructure works, announces a significant update in its business devel…
Phoenix Asia Holdings Limited Announces Unaudited Financial Results For The Six Months Ended September 30, 2025
Hong Kong, March 31, 2026 (GLOBE NEWSWIRE) -- Phoenix Asia Holdings Limited (“PHOE” or the “Company”) (Nasdaq: PHOE) is an exempted company with limited liability incorporated under the laws of the Cayman Islands with no material operations…
Affinity Partners Brings Leading Global Investors into Phoenix, Remains Largest Shareholder with a Significant Long-Term Ownership Position
Affinity Partners today announced the entry of a small number of the world's premier long-only asset managers into Phoenix Financial's shareholder base, further strengthening the company's ownership structure and broadening its internationa…
Phoenix Financial Joins MSCI World Index
Phoenix Financial, a leading Israel-based asset management, insurance, and financial services group (TASE: PHOE) ("Phoenix" or the "Company"), announced the inclusion of the company in the leading MSCI World index. MSCI World is widely used…
Is Phoenix Asia Holdings Limited's (NASDAQ:PHOE) ROE Of 33% Impressive?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
PHOE — Frequently Asked Questions
What is the current share price of PHOE?
As of 2026-08-05 17:25 PDT, PHOE trades at $19.50 on NASDAQ/NYSE. Its 52-week range is $7.09 to $133.12.
What is the market capitalisation of PHOE?
PHOE has a market capitalisation of $421.20M on NASDAQ/NYSE.
What is the P/E ratio of PHOE?
PHOE trades at a trailing price-to-earnings (P/E) ratio of 398.64. Its price-to-book (P/B) ratio is 135.42.
What is the return on equity (ROE) of PHOE?
PHOE has a return on equity (ROE) of 33.00%. Its return on capital employed (ROCE) is 41.45%.
Is PHOE a good stock to buy?
This page provides a data-driven analysis of PHOE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.